Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vinay Prasad

Why Is Replimune Stock Trading Lower On Monday?

On Monday, Replimune Group Inc. (NASDAQ:REPL) is reeling after the FDA unexpectedly rejected its skin cancer treatment, triggering a stock plunge and a wave of investor outrage.

Benzinga

Laura Loomer just admitted she’s running a ‘tip line’ to get Trump officials fired and predicts ‘hundreds’ more pink slips

Loomer's purge machine.

We Got This Covered

‘Progressive leftist saboteur’: How Laura Loomer’s single-handely got Donald Trump’s choice fired

Loomer's latest victory.

We Got This Covered

From analysis to the latest developments in health,
read the most diverse news in one place.

Vinay Prasad vs the FDA: How One Doctor's Policies Collided with Politics and Cost Him His Job

Vinay Prasad resigns from the FDA after backlash over vaccine restrictions and gene therapy decisions. Political pressure cited in sudden departure.

International Business Times UK

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

In May, FDA Commissioner Marty Makary named Vinay Prasad the next director of the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER). Within three months, Prasad resigned.

Benzinga

FDA’s top vaccine official leaves post after less than four months

Trump administration gives no details about reason for departure of Vinay Prasad, but he had critics and had taken unusual actions

The Guardian - US

FDA names former pharmaceutical company executive to oversee US drug program

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

‘Tremendous uncertainty’ for cancer research as US officials target mRNA vaccines

Amid Trump cuts and state-level backlash, experts worry that progress in messenger RNA vaccines could stall

The Guardian - US

FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months

The U.S. Food and Drug Administration (FDA) has approved Moderna Inc.’s (NASDAQ:MRNA) supplemental Biologics License Application (sBLA) for Spikevax, the company’s COVID-19 vaccine, in children six months through 11 years of age who are at increased risk for COVID-19 disease.

Benzinga

FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines

The Independent UK

A ‘war on children’: as US changes Covid vaccine rules, parents of trial volunteers push back

Frustration and anger mount as Trump administration contemplates new trials and restrictions for Covid vaccines

The Guardian - US

RFK Jr. says annual COVID-19 shots no longer advised for healthy children and pregnant women – a public health expert explains the new guidance

On May 27, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. announced that the Centers for Disease Control and Prevention will no longer include the COVID-19 vaccine on the list of immunizations it recommends for healthy children and pregnant women.

The Conversation

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter

The Independent UK

FDA won’t approve COVID shot for healthy, non-elderly population - Roll Call

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials.

Roll Call

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

FDA will approve COVID-19 vaccine only for older adults and high-risk groups – a public health expert explains the new rules

On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.

The Guardian - US

FDA says it will limit access to Covid-19 boosters for Americans under 65

Critics say shift will negatively affect people who are not high risk but want to be vaccinated against the disease

The Independent UK

RFK Jr. pledged not to upend US vaccine system, but big changes are underway

Health agencies working under Robert F

The Guardian - US

Critic of Covid boosters set to enact tough agenda as top US vaccines official

Vinay Prasad, outspoken critic of pharmaceutical industry and of his peers in public health, to take over CBER

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

FDA names a new vaccine chief. He is a vocal critic of the agency

Prasad is a YouTuber who comments on popular issues in health and politics

The Independent UK

Critic of drug industry and COVID-19 measures to lead FDA vaccine program

The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its vaccine center

Reason

Vinay Prasad: What Does RFK Jr. Get Right and Wrong?

YouTuber Dr. Vinay Prasad joins Just Asking Questions Live on Tuesday November 26 at 1 p.m. EST.

Reason

The COVID-19 Vaccines Shouldn't Have Been Free

So many problems would have disappeared if we had treated them like a normal product.

Reason

Dr. Vinay Prasad: You're Right Not To Trust Public Health

The outspoken critic of the CDC and FDA explains what went wrong—and what went right—with COVID policy.

Reason

Dr. Vinay Prasad: Stop Trusting the Public Health Establishment

Join Reason on YouTube at 1 p.m. Eastern for a discussion of mRNA vaccines and America's public health establishment with UCSF's Vinay Prasad.

Reason

Against Scientific Gatekeeping

Science should be a profession, not a priesthood.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Health and Human Services

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.